251 related articles for article (PubMed ID: 35444934)
1. Immunogenic Cell Death-Relevant Damage-Associated Molecular Patterns and Sensing Receptors in Triple-Negative Breast Cancer Molecular Subtypes and Implications for Immunotherapy.
Xu M; Lu JH; Zhong YZ; Jiang J; Shen YZ; Su JY; Lin SY
Front Oncol; 2022; 12():870914. PubMed ID: 35444934
[TBL] [Abstract][Full Text] [Related]
2. Damage-associated molecular patterns and sensing receptors based molecular subtypes in malignant pleural mesothelioma and implications for immunotherapy.
Liu Z; Wan R; Bai H; Wang J
Front Immunol; 2023; 14():1104560. PubMed ID: 37033966
[TBL] [Abstract][Full Text] [Related]
3. An immunogenic cell death-related classification predicts response to immunotherapy and prognosis in triple-negative breast cancer.
Cheng XY; Liang Y; Zhang HF; Qian FZ; Sun XH; Liu XA
Am J Transl Res; 2023; 15(4):2598-2609. PubMed ID: 37193173
[TBL] [Abstract][Full Text] [Related]
4. Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer.
Li J; Li Z; Yang W; Pan J; You H; Yang L; Zhang X
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2007. PubMed ID: 38425247
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer.
Zhu L; Wu Y; Zhao H; Guo Z; Bo B; Zheng L
Sci Rep; 2024 Jan; 14(1):2025. PubMed ID: 38263419
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma.
Peng W; Yang J; Xia L; Qian X; Long G; Zhang H; Xie J; Zhao J; Zhang L; Pan W
Front Oncol; 2023; 13():1178966. PubMed ID: 37064149
[TBL] [Abstract][Full Text] [Related]
7. A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype.
Chen Z; Wang M; De Wilde RL; Feng R; Su M; Torres-de la Roche LA; Shi W
Front Immunol; 2021; 12():749459. PubMed ID: 34603338
[TBL] [Abstract][Full Text] [Related]
8. A damage-associated molecular patterns-related gene signature for the prediction of prognosis and immune microenvironment in children stage III acute lymphoblastic leukemia.
Zhao F; Lin Q; Xiang X; Xiang W
Front Pediatr; 2022; 10():999684. PubMed ID: 36340735
[TBL] [Abstract][Full Text] [Related]
9. A senescence-associated signature refines the classification of different modification patterns and characterization of tumor immune microenvironment infiltration in triple-negative breast cancer.
Huang R; Wang H; Hong J; Wang Z; Wu J; Huang O; He J; Chen W; Li Y; Chen X; Shen K
Front Pharmacol; 2023; 14():1191910. PubMed ID: 37251343
[No Abstract] [Full Text] [Related]
10. Characterization of Pyroptosis-Related Subtypes
Li C; Pan J; Jiang Y; Wu Y; Jin Z; Chen X
Front Genet; 2022; 13():788670. PubMed ID: 35386285
[TBL] [Abstract][Full Text] [Related]
11. CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer.
Cheng T; Wu Y; Liu Z; Yu Y; Sun S; Guo M; Sun B; Huang C
Front Immunol; 2022; 13():970950. PubMed ID: 36052076
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers.
Korlimarla A; Ps H; Prabhu J; Ragulan C; Patil Y; Vp S; Desai K; Mathews A; Appachu S; Diwakar RB; Bs S; Melcher A; Cheang M; Sadanandam A
Transl Oncol; 2022 Nov; 25():101511. PubMed ID: 35964339
[TBL] [Abstract][Full Text] [Related]
13. Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer.
Hu S; Qu X; Jiao Y; Hu J; Wang B
Front Genet; 2021; 12():710534. PubMed ID: 34795691
[No Abstract] [Full Text] [Related]
14. Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial.
Jiang YZ; Liu Y; Xiao Y; Hu X; Jiang L; Zuo WJ; Ma D; Ding J; Zhu X; Zou J; Verschraegen C; Stover DG; Kaklamani V; Wang ZH; Shao ZM
Cell Res; 2021 Feb; 31(2):178-186. PubMed ID: 32719455
[TBL] [Abstract][Full Text] [Related]
15. An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma.
Wang X; Wu S; Liu F; Ke D; Wang X; Pan D; Xu W; Zhou L; He W
Front Immunol; 2021; 12():781466. PubMed ID: 34868055
[TBL] [Abstract][Full Text] [Related]
16. Combination of Immune-Related Network and Molecular Typing Analysis Defines a Three-Gene Signature for Predicting Prognosis of Triple-Negative Breast Cancer.
Zhang J; Pan S; Han C; Jin H; Sun Q; Du J; Han X
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358906
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome-Based Network Analysis Unveils Eight Immune-Related Genes as Molecular Signatures in the Immunomodulatory Subtype of Triple-Negative Breast Cancer.
Zhang J; Wang L; Xu X; Li X; Guan W; Meng T; Xu G
Front Oncol; 2020; 10():1787. PubMed ID: 33042828
[No Abstract] [Full Text] [Related]
18. Molecular Classification Models for Triple Negative Breast Cancer Subtype Using Machine Learning.
Bissanum R; Chaichulee S; Kamolphiwong R; Navakanitworakul R; Kanokwiroon K
J Pers Med; 2021 Sep; 11(9):. PubMed ID: 34575658
[TBL] [Abstract][Full Text] [Related]
19. A marine-derived small molecule induces immunogenic cell death against triple-negative breast cancer through ER stress-CHOP pathway.
Wen H; Zhong Y; Yin Y; Qin K; Yang L; Li D; Yu W; Yang C; Deng Z; Hong K
Int J Biol Sci; 2022; 18(7):2898-2913. PubMed ID: 35541893
[TBL] [Abstract][Full Text] [Related]
20. Integrated multi-cohorts for characterizing the immunogenomic landscape and predicting drug response in triple-negative breast cancer.
Su D; Chi M; Wang S; Di S; Zhang H; Lu Q; Yu Y; Xiong Y; Wei H; Lv Y; Zuo Y; Yang L
Brief Funct Genomics; 2022 May; 21(3):188-201. PubMed ID: 35348574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
